BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28517443)

  • 1. SU-E-T-467: Monte Carlo Dosimetric Study of the New Flexisource Co-60 High Dose Rate Source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2012 Jun; 39(6Part17):3812. PubMed ID: 28517443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo dosimetric study of the Flexisource Co-60 high dose rate source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    J Contemp Brachytherapy; 2012 Mar; 4(1):34-44. PubMed ID: 23346138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo dosimetric study of the medium dose rate CSM40 source.
    Vijande J; Granero D; Perez-Calatayud J; Ballester F
    Appl Radiat Isot; 2013 Dec; 82():283-8. PubMed ID: 24121444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo dosimetric characterization of the Flexisource Co-60 high-dose-rate brachytherapy source using PENELOPE.
    Almansa JF; Guerrero R; Torres J; Lallena AM
    Brachytherapy; 2017; 16(5):1073-1080. PubMed ID: 28669539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison between microSelectron iridium-192 and flexi cobalt-60 sources in high-dose-rate brachytherapy using Geant4 Monte Carlo code.
    Gebremariam TY; Geraily G; Jassim HH; Gholami S
    J Contemp Brachytherapy; 2023 Apr; 15(2):141-147. PubMed ID: 37215615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2.
    Granero D; Vijande J; Ballester F; Rivard MJ
    Med Phys; 2011 Jan; 38(1):487-94. PubMed ID: 21361217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A revised dosimetric characterization of the model S700 electronic brachytherapy source containing an anode-centering plastic insert and other components not included in the 2006 model.
    Hiatt JR; Davis SD; Rivard MJ
    Med Phys; 2015 Jun; 42(6):2764-76. PubMed ID: 26127029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Monte Carlo study on dose distribution evaluation of Flexisource (192)Ir brachytherapy source.
    Alizadeh M; Ghorbani M; Haghparast A; Zare N; Ahmadi Moghaddas T
    Rep Pract Oncol Radiother; 2015; 20(3):204-9. PubMed ID: 25949224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of (101)Rh as a brachytherapy source.
    Pakravan D; Ghorbani M; Meigooni AS
    J Contemp Brachytherapy; 2015 Apr; 7(2):171-80. PubMed ID: 26034499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric study of GZP6
    Lei Q; Xu A; Gou C; Wen Y; He D; Wu J; Hou Q; Wu Z
    J Appl Clin Med Phys; 2018 Jul; 19(4):313-318. PubMed ID: 29808551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BEBIG
    Joya M; Nedaie HA; Geraily G; Ghorbani M; Sheikhzadeh P; Arani MN
    Heliyon; 2022 Mar; 8(3):e09168. PubMed ID: 35368537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source.
    Granero D; Pérez-Calatayud J; Ballester F
    Radiother Oncol; 2005 Jul; 76(1):79-85. PubMed ID: 16019091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TG-43 U1 based dosimetric characterization of model 67-6520 Cs-137 brachytherapy source.
    Meigooni AS; Wright C; Koona RA; Awan SB; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2009 Oct; 36(10):4711-9. PubMed ID: 19928102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.